Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2023
Programm
Personen
Suche
EN
Zurück
ePoster
P019
Benefit-Risk assessment of atogepant vs. placebo in participants with episodic migraine who had prior inadequate response to 2–4 classes of oral preventive treatment: a post-hoc analysis of the ELEVATE trial
Uwe Reuter
Berlin, DE
Termin
Datum:
06.12.2023
Zeit:
19:30
–
19:35
Redezeit:
3 Min.
Diskussionszeit:
2 Min.
Ort / Stream:
Headache theatre
Poster
Benefit-Risk assessment of atogepant vs. placebo in participants with episodic migraine who had prior inadequate response to 2–4 classes of oral preventive treatment: a post-hoc analysis of the ELEVATE trial
Session
ePoster 02
Thema
New developments in prophylactic medications and acute medications
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz